HS
HighVista Strategies’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-86,103
| Closed | -$893K | – | 133 |
|
|
2023
Q2 | $893K | Sell |
86,103
-111,700
| -56% | -$1.16M | 0.41% | 58 |
|
|
2023
Q1 | $1.6M | Buy |
197,803
+10,184
| +5% | +$82.4K | 1.3% | 29 |
|
|
2022
Q4 | $2.95M | Sell |
187,619
-30,199
| -14% | -$476K | 1.75% | 13 |
|
|
2022
Q3 | $3.43M | Buy |
217,818
+290
| +0.1% | +$4.56K | 1.96% | 13 |
|
|
2022
Q2 | $3.04M | Buy |
217,528
+59,285
| +37% | +$828K | 1.83% | 14 |
|
|
2022
Q1 | $2.73M | Buy |
158,243
+46,083
| +41% | +$794K | 1.73% | 16 |
|
|
2021
Q4 | $1.63M | Buy |
112,160
+19,160
| +21% | +$279K | 1.3% | 18 |
|
|
2021
Q3 | $1.68M | Buy |
93,000
+53,325
| +134% | +$960K | 1.11% | 15 |
|
|
2021
Q2 | $697K | Buy |
+39,675
| New | +$697K | 0.49% | 63 |
|